Navigation Links
ADVENTRX Announces Restructuring and Cost Reduction Initiatives
Date:10/20/2008

essary to meet its goals, including funding the continued development and commercialization of ANX-530 or ANX-514; the risk the FDA will determine that ANX-530 and Navelbine are not bioequivalent, including as a result of performing pharmacokinetic equivalence analysis based a patient population other than the population on which ADVENTRX based its analysis; the risk that the on-going clinical study of ANX-514 does not demonstrate pharmacokinetic equivalence or bioequivalence; the risk of investigator bias in reporting adverse events as a result of the open-label nature of the ANX-530 bioequivalence clinical study, including bias that increased the reporting of adverse events associated with Navelbine and/or that decreased the reporting of adverse events associated with ANX-530; difficulties or delays in manufacturing, obtaining regulatory approval for and marketing ANX-530 and ANX- 514, including validating commercial manufacturers and suppliers and the potential for automatic injunctions regarding FDA approval of ANX-514; the potential for regulatory authorities to require additional preclinical work or other clinical requirements to support regulatory filings, including prior to the submission or the approval of an NDA for ANX-530 and ANX-514; the risk that the performance of third parties on whom ADVENTRX relies to conduct its studies or evaluate the data, including clinical investigators, expert data monitoring committees, contract laboratories and contract research organizations, may be substandard, or they may fail to perform as expected; and other risks and uncertainties more fully described in ADVENTRX's press releases and periodic filings with the Securities and Exchange Commission. ADVENTRX's public filings with the Securities and Exchange Commission are available at http://www.sec.gov.

You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date wh
'/>"/>

SOURCE ADVENTRX Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. ADVENTRX Pharmaceuticals to Report Second Quarter 2008 Results
2. ADVENTRX Settles Dispute With Former Licensee
3. ADVENTRX Pharmaceuticals to Present at the Rodman & Renshaw 5th Annual Global Healthcare Conference
4. ADVENTRX Appoints Vice President of Manufacturing
5. ADVENTRX Creates Executive Vice President Position and Announces New Chief Financial Officer
6. ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2007 Financial Results
7. ADVENTRX Pharmaceuticals to Report Fourth Quarter and Year End 2007 Results
8. Eric K. Rowinsky Joins ADVENTRX Board of Directors
9. ADVENTRX to Present Complete ANX-530 Pharmacokinetic Data at the 2008 American Association for Cancer Research Annual Meeting
10. ADVENTRX Announces Consolidation of Clinical and Management Positions
11. ADVENTRX Pharmaceuticals Reports Third Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... Reed Technology and Information Services ... management, preparation, and submission to the U.S. Food and ... new Lot Distribution Report (LDR) service for manufacturers of ... with the FDA’s new rule on electronic submission of ... the volume and timing of particular biologics introduced to ...
(Date:4/17/2015)... April 17, 2015  Guggenheim Securities, the investment banking ... the hiring of William Tanner as a ... Mr. Tanner will start work at Guggenheim in May ... office. "Bill brings a wealth of ... our experienced and highly acclaimed healthcare team," said ...
(Date:4/17/2015)... 17, 2015 LC Sciences LLC, ... announced today that it is seeking beta testers ... multiplex PCR based targeted sequencing technology. The system ... that enables accurate detection of rare variants. It ... technologies. The company will collaborate with beta testers ...
(Date:4/16/2015)... and OSAKA, Japan , April ... Application (CiRA) of Kyoto University and Takeda Pharmaceutical ... work together to develop clinical applications of induced ... failure, diabetes mellitus, neurological disorders and cancer immunotherapy. ... (T-CiRA) is designed to expedite multiple research projects ...
Breaking Biology Technology:Reed Tech Announces FDA Lot Distribution Report (LDR) Service for Manufacturers of Biologic Products 2Reed Tech Announces FDA Lot Distribution Report (LDR) Service for Manufacturers of Biologic Products 3Guggenheim Securities Hires Biotech Analyst William Tanner in Expansion of Healthcare Coverage 2LC Sciences Seeks Beta Testers of Targeted Sequencing Method Ahead of Q4 Launch 2LC Sciences Seeks Beta Testers of Targeted Sequencing Method Ahead of Q4 Launch 3CiRA and Takeda Enter 10-year Collaboration on iPS Cell Research 2CiRA and Takeda Enter 10-year Collaboration on iPS Cell Research 3
... in Janesville last week as General Motors announced it will ... a decision that will keep high-wage manufacturing jobs in southern ... in the Janesville line means the plant will stay open ... whether the plants total of 3,900 jobs will grow or ...
... of North Prairie, Wisconsin, has signed a contract with ... new software is fully integrated with the rest of ... chain management and financial applications, which the company implemented ... cases used primarily by grocery, convenience, and drug store ...
... Information Systems employees will be participating for the ... management students at Blackhawk Technical College , located ... a comprehensive experience for students as they research a ... technology business solutions to local businesses. , ,As ...
Cached Biology Technology:GM Choice is Great News, But Wisconsins Economy Must Keep on Truckin to Prosper in a New Era 2Zero Zone Adds Sales and Marketing Automation Tools 2
(Date:3/19/2015)... , March 19, 2015  NXT-ID, Inc. (NASDAQ: ... company focused on the growing mobile commerce market, announces its ... a news clip that aired this week on ... . In a segment "The Next Great Thing", ... ,a new way to pay, and ,a really big breakthrough ...
(Date:3/17/2015)... Minn. , March 17, 2015 ... technology company specializing in clinical study management systems, ... be in attendance at ARENA,s Outsourcing in Clinical ... NC.  This event provides an excellent forum for ... easy-to-use, flexible and affordable software-as-a-service (SaaS) eClinical technology ...
(Date:3/17/2015)... YORK , March 17, 2015  MecklerMedia ... the largest exhibition for service robots ever held ... RoboUniverse takes place on May 11-13, 2015 at ... and exhibitors for the event include: Acorn Product ... Control; EZ-Robot; Infranor; Kinova Robotics; Littler; NewBotic Corporation; ...
Breaking Biology News(10 mins):NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 2NXT-ID's Wocket Smart Wallet Featured on Fox News Segment, "The Next Great Thing" 3Connect With MedNet Solutions At Outsourcing In Clinical Trials Southeast 2MecklerMedia's RoboUniverse New York Announces Sponsors and Exhibitors, May 11-13, 2015 2
... "smart village" built in Malaysia provides a potential ... sustainable environment, say international experts meeting in California,s ... built north-east of Kuala Lumpur, consists of 100 ... and a creative, closed-loop agricultural system designed to ...
... Orleans, LA Research conducted by Jesus Lovera, MD, Assistant ... and colleagues has shown that stress management treatment significantly reduced ... sclerosis (MS) over the course of treatment. These lesions are ... The work is published ahead of print and is now ...
... determine much about you, but environment can have a strong ... can last a lifetime. In a study published online ... for the first time shown that the environment experienced in ... to DNA we are born with, that could have implications ...
Cached Biology News:Pioneering self-contained 'smart village' offers world model for rural poverty relief 2Pioneering self-contained 'smart village' offers world model for rural poverty relief 3Pioneering self-contained 'smart village' offers world model for rural poverty relief 4LSUHSC research finds treating stress prevented new MS brain lesions 2Differences between human twins at birth highlight importance of intrauterine environment 2
... Anti-T7 [Agarose Immobilized] Goat Immunogen: ... site (MASMTGGQQMG). Antibody was isolated ... on solid support. Goat anti- human T7 ... beads using cyanogens bromide method. ...
Rabbit polyclonal to Olfactory Receptor LS189744 ( Abpromise for all tested applications)....
C/EBPdelta Antibody Shipping Temperature: Cold Storage Temperature: -20C...
Ubiquitin-like protein 4A (Ubiquitin-like protein GDX). [Source:Uniprot/SWISSPROT;Acc:P11441] Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
Biology Products: